CorMedix
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $11,456 | $806 | $0 | $304 |
Gross Profit | 10,769 | 296 | -818 | 250 |
EBITDA | -2,652 | -14,031 | -15,793 | -14,700 |
EBIT | -2,766 | -14,144 | -15,851 | -14,754 |
Net Income | -2,776,812 | -14,151 | -14,466 | -14,754 |
Net Change In Cash | 11,456 | 806 | 0 | 304 |
Free Cash Flow | -13,659 | -14,074 | -17,371 | -11,041 |
Cash | 35,286 | 28,540 | 35,256 | 43,720 |
Basic Shares | 58,825 | 57,620 | 57,503 | 57,393 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $65 | $190 | $239 |
Gross Profit | -205 | 61 | 41 | 34 |
EBITDA | -48,887 | -30,051 | -29,375 | -27,020 |
EBIT | -48,957 | -30,260 | -29,552 | -27,163 |
Net Income | -46,339 | -29,701 | -28,210 | -22,027 |
Net Change In Cash | 0 | 65 | 190 | 239 |
Cost of Revenue | 11,454 | 25,571 | ||
Free Cash Flow | -38,736 | -24,576 | -22,580 | -22,080 |
Cash | 43,642 | 43,374 | 53,551 | 42,096 |
Basic Shares | 50,902 | 40,274 | 37,666 | 28,561 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.05 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.26 |
